Mollie Leoni
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Mollie Leoni is currently Chief Medical Officer at Kura Oncology, Inc. since 2025.
Formerly, worked as Executive Director-Medical Science at Kyowa Kirin Ltd. from 2018 to 2020 and at Kyowa Kirin Co., Ltd. Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KURA ONCOLOGY, INC. 0,21% | 18-06-2026 | 182.345 ( 0,21% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| KURA ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 02-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-02-2020 |
| KYOWA KIRIN CO., LTD. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau